SGLT2抑制剂对血尿酸影响的研究进展
Journal of Modern Clinical Medicine(2021)
Abstract
新型降糖药物钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂在降糖的同时不仅可改善2型糖尿病患者心血管及肾脏结局,亦可降低血尿酸水平,机制可能与增加尿糖排泄及渗透性利尿有关.本文就SGLT2抑制剂研究现状及对血尿酸影响机制、特点、获益等几个方面进行综述,旨在为高尿酸血症患者的治疗提供参考.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined